Showing 15 posts of 749 posts found.

AZ signs tuberculosis drug discovery deal

May 6, 2010
Research and Development AstraZeneca, India, TB, tuberculosis

AstraZeneca and the Global Alliance for TB Drug Development are to collaborate on the discovery and development of drugs to treat tuberculosis.The two …


Crestor gains prevention licence in Europe

April 27, 2010
Sales and Marketing AstraZeneca, Crestor, statin

AstraZeneca’s statin treatment Crestor has been approved in the European Union for the prevention of major cardiovascular events in patients …

European approval for ‘double strength’ Faslodex

March 19, 2010
Sales and Marketing AstraZeneca, Faslodex, breast cancer

AstraZeneca’s Faslodex has expanded its European licence after winning approval to treat women with hormone receptor-positive breast cancer in a …

UK hit hard as AstraZeneca reveals R&D cuts

March 3, 2010
Research and Development AstraZeneca, job cuts

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …

Brennan rejects generics diversification model

February 11, 2010
Sales and Marketing AstraZeneca, biosimilars, em, generics, industry

AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010
Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …

BBC highlights AZ’s Seroquel woes

January 27, 2010
Sales and Marketing AstraZeneca, Seroquel, industry reputation

AstraZeneca’s ongoing US legal battle over its antipsychotic drug Seroquel was highlighted this week in a BBC radio programme. AstraZeneca …

AstraZeneca continues personalised healthcare push

January 19, 2010
Sales and Marketing AstraZeneca, Dako, Diagnostics, Iressa

AstraZeneca and cancer diagnostics specialist Dako Denmark are to develop companion diagnostics for a number of the pharma company’s oncology …

AstraZeneca taps Korean firm for antibiotics

January 15, 2010
Research and Development Asia, AstraZeneca, CrystalGenomics, Korea, anti-infectives

AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …


AstraZeneca’s Bruno Angelici awarded Légion d`honneur

January 8, 2010
Sales and Marketing AstraZeneca, France, appointment, sales and marketing

AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …

AstraZeneca signs deals to increase anti-infective portfolio

January 7, 2010
Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …


AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience

December 15, 2009
Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing

AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …

Dr Jan Lundberg to succeed Dr Steven Paul as head of Lilly Research Laboratories

November 27, 2009
Research and Development AstraZeneca, appointment, appt, lilly, research and development

Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …

AstraZeneca's Health Connections blog

Digital Pharma: AstraZeneca joins the blogosphere

November 26, 2009
Medical Communications AstraZeneca, blog, digi, digital pharma

AstraZeneca recently launched its first official corporate blog, joining the likes of Johnson & Johnson and

AstraZeneca's Google sidewiki entry

Digital Pharma: Reacting to sidewiki

November 18, 2009
Medical Communications AstraZeneca, digi, digital pharma, google, sidewiki

Over the last two months pharmaceutical company websites have been plagued by unwanted, un-moderated comments thanks to Google’s sidewiki.The search …

Latest content